Skip to main content

Table 3 Results of association between CTCs and clinicopathological characteristics

From: Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis

  OR (95% CI) N P-value
Age: > 65 vs. ≤65(OR) 1.07 (0.62,1.87) I2 = 0% 4 0.8
Sex: male vs. female (OR) 1.01 (0.53,1.91) I2 = 0% 5 0.98
Histology: AC vs. SCC 1.86 (0.81,4.26) I2 = 0% 4 0.14
pT: T3/T4 vs. T1/T2(OR) 2.92 (1.31,6.51) I2 = 0% 3 0.009
LN3 vs. LN [2](OR) 1.06 (0.61,1.86) I2 = 0% 4 0.83
pM:M1 vs. M0(OR) 5.18 (2.38,11.25) I2 = 0% 4 < 0.001
Stage: III/IV vs. I/II (OR) 1.36 (0.68,2.71) I2 = 0% 3 0.38
  1. OR Odds ratio
  2. P-value for estimates of OR
  3. “-”: not available
  4. LN Lymph node